Skip to main content
14 hours ago

FDA clears Artrya’s heart health tool

14 hours ago

Bookmark

Save articles for future reference.

Artrya has cleared a regulatory hurdle in the US, allowing it to charge fees for its AI-powered heart disease assessments.

X

To read our articles you will need to either login or subscribe.